Obesity, diabetes and pneumonia: The menacing interface of non-communicable and infectious diseases

Tropical Medicine and International Health

Volumn 18, Issue 12, 2013, Pages 1510-1519

  Fisher Hoch, Susan P ^a   Mathews, Christine E ^a   Mccormick, Joseph B ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Chronic inflammation; Diabetes; Obesity; Pneumonia

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

DIABETES; DRUG RESISTANCE; INFLUENZA; LITERATURE REVIEW; MORBIDITY; MORTALITY; OBESITY; PNEUMONIA; TUBERCULOSIS;

ADAPTIVE IMMUNITY; ARTICLE; DIABETES MELLITUS; EMBASE; HUMAN; IMMUNOPATHOLOGY; INCOME; INFECTION; INFLUENZA; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL LITERATURE; MEDLINE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PNEUMOCOCCAL INFECTION; PNEUMONIA; PROPHYLAXIS; STREPTOCOCCUS PNEUMONIA; SYSTEMATIC REVIEW; TUBERCULOSIS; TUBERCULOSIS CONTROL; UPREGULATION;

CHRONIC INFLAMMATION; DIABETES; OBESITY; PNEUMONIA;

DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; OBESITY; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; RISK FACTORS; TUBERCULOSIS, PULMONARY; WORLD HEALTH;

EID: 84888005577     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12206     Document Type: Article

References (101)

1. Abrass CK (1991) Fc-receptor-mediated phagocytosis: abnormalities associated with diabetes mellitus. Clinical Immunology and Immunopathology 58, 1-17.
2. Aldridge JR Jr, Moseley CE, Boltz DA et al. (2009) TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proceedings of the National Academy of Sciences of the United States of America 106, 5306-5311.
3. Allard R, Leclerc P, Tremblay C & Tannenbaum TN (2010) Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care 33, 1491-1493.
4. Andreasen AS, Pedersen-Skovsgaard T, Berg RM et al. (2010) Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia. Intensive Care Medicine 36, 1548-1555.
5. Asghar AH, Ashshi AM, Azhar EI, Bukhari SZ, Zafar TA & Momenah AM (2011) Profile of bacterial pneumonia during Hajj. Indian Journal of Medical Research 133, 510-513.
6. Baker MA, Harries AD, Jeon CY et al. (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Medicine 9, 81.
7. Bastard JP, Maachi M, Lagathu C et al. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network 17, 4-12.
8. Bell J & Hockaday T (1996) Diabetes Mellitus. In: Oxford Textbook of Medicine 3rd edn (eds DJ Wetherall, JGG Ledingham & DA Warrell ) Oxford University Press, Oxford, pp. 1448-1504.
9. Bertoni AG, Saydah S & Brancati FL (2001) Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care 24, 1044-1049.
10. Bloom DE, Cafiero ET, Jane-Llopis E et al. (2011) The Global Economic Burder of Non-Communicable Diseases. 1-46. World Economic Forum, Geneva, Switzerland, 1-46.
11. Breen JD & Karchmer AW (1995) Staphylococcus aureus infections in diabetic patients. Infectious Disease Clinics of North America 9, 11-24.
12. Bygbjerg IC (2012) Double burden of noncommunicable and infectious diseases in developing countries. Science 337, 1499-1501.
13. Centers for Disease Control and Prevention (2006) Chronic Disease Prevention: Preventing Diabetes and its Complications.
14. Centers for Disease Control and Prevention (2009) Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. Morbidity and Mortality Weekly Report 58, 749-752.
15. Centers for Disease Control and Prevention (2013) Information on Avian Influenza. Department of Health and Human Services.
16. Chang FY & Shaio MF (1995) Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Research and Clinical Practice 28, 137-146.
17. Dooley KE & Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet Infectious Diseases 9, 737-746.
18. Droemann D, Aries SP, Hansen F et al. (2000) Decreased apoptosis and increased activation of alveolar neutrophils in bacterial pneumonia. Chest 117, 1679-1684.
19. Dye C & Williams BG (2010) The population dynamics and control of tuberculosis. Science 328, 856-861.
20. Dye C, Bourdin TB, Lonnroth K, Roglic G & Williams BG (2011) Nutrition, diabetes and tuberculosis in the epidemiological transition. PLoS One 6, e21161.
21. Falagas ME, Athanasoulia AP, Peppas G & Karageorgopoulos DE (2009) Effect of body mass index on the outcome of infections: a systematic review. Obesity Reviews 10, 280-289.
22. Fantuzzi G & Faggioni R (2000) Leptin in the regulation of immunity, inflammation, and hematopoiesis. Journal of Leukocyte Biology 68, 437-446.
23. Fedson DS & Scott JA (1999) The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 17(Suppl. 1), S11-S18.
24. Feuerer M, Herrero L, Cipolletta D et al. (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Medicine 15, 930-939.
25. Gill JR, Sheng ZM, Ely SF et al. (2010) Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Archives of Pathology and Laboratory Medicine 134, 235-243.
26. Goldhaber-Fiebert JD, Jeon CY, Cohen T & Murray MB (2011) Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. International Journal of Epidemiology 40, 417-428.
27. Hall V, Thomsen RW, Henriksen O & Lohse N (2011) Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health 11, 564.
28. Harries AD, Billo N & Kapur A (2009) Links between diabetes mellitus and tuberculosis: should we integrate screening and care? Transactions of the Royal Society of Tropical Medicine and Hygiene 103, 1-2.
29. Harries AD, Murray MB, Jeon CY et al. (2010) Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Tropical Medicine and International Health 15:659-663. NIHMS ID: 259253.
30. Harries AD, Yan L, Srinath S et al. (2011) The looming epidemic of diabetes-associated tuberculosis-learning lessons from HIV-associated tuberculosis. Tropical Medicine and International Health 15, 659-663.
31. Horton R (2013) Non-communicable diseases: 2015 to 2025. Lancet 381, 509-510.
32. Ikejima S, Sasaki S, Sashinami H et al. (2005) Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice. Diabetes 54, 182-189.
33. International Diabetes Federation (2012) IDF Diabetes Atlas, 5th edn. [article online] . http://www.idf.org/diabetesatlas/5e/the-global-burden. Accessed 4 April 2012.
34. Jagannathan-Bogdan M, McDonnell ME, Shin H et al. (2011) Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. The Journal of Immunology 186, 1162-1172.
35. Jeon CY & Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Medicine 5, e152.
36. Jeon CY, Harries AD, Baker MA et al. (2010) Bi-directional screening for tuberculosis and diabetes: a systematic review. Tropical Medicine and International Health 15, 1300-1314.
37. Jimenez-Corona ME, Cruz-Hervert LP, Garcia-Garcia L et al. (2013) Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 68, 214-220.
38. Johnson NP & Mueller J (2002) Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bulletin of the History of Medicine 76, 105-115.
39. Joshi N, Caputo GM, Weitekamp MR & Karchmer AW (1999) Infections in patients with diabetes mellitus. New England Journal of Medicine 341, 1906-1912.
40. Kobayashi SD, Braughton KR, Palazzolo-Ballance AM et al. (2010) Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. Journal of Innate Immunity 2, 560-575.
41. Kopelman PG (2000) Obesity as a medical problem. Nature 404, 635-643.
42. Kornum JB, Norgaard M, Dethlefsen C et al. (2010) Obesity and risk of subsequent hospitalisation with pneumonia. European Respiratory Journal 36, 1330-1336.
43. 2+]i and the impairment of phagocytosis in PMNLs of NIDDM patients. Kidney International 64, 2188-2195.
44. Lamas O, Marti A & Martinez JA (2002) Obesity and immunocompetence. European Journal of Clinical Nutrition 56(Suppl. 3), S42-S45.
45. Leibovici L, Yehezkelli Y, Porter A, Regev A, Krauze I & Harell D (1996) Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections. Diabetic Medicine 13, 457-463.
46. Leung CC, Lam TH, Chan WM et al. (2008) Diabetic control and risk of tuberculosis: a cohort study. American Journal of Epidemiology 167, 1486-1494.
47. Lin Y, Li L, Mi F et al. (2012) Screening patients with Diabetes Mellitus for Tuberculosis in China. Tropical Medicine and International Health 17, 1302-1308.
48. Lipsky BA, Pecoraro RE, Chen MS & Koepsell TD (1987) Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 10, 483-486.
49. Macia L, Delacre M, Abboud G et al. (2006) Impairment of dendritic cell functionality and steady-state number in obese mice. The Journal of Immunology 177, 5997-6006.
50. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW & Huffnagle GB (2002) Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. The Journal of Immunology 168, 4018-4024.
51. Marhoffer W, Stein M, Schleinkofer L & Federlin K (1994) Monitoring of polymorphonuclear leukocyte functions in diabetes mellitus-a comparative study of conventional radiometric function tests and low-light imaging systems. Journal of Bioluminescence and Chemiluminescence 9, 165-170.
52. Mathews CE, Brown EL, Martinez PJ et al. (2012) Impaired function of antibodies to pneumococcal surface protein a but not to capsular polysaccharide in mexican american adults with type 2 diabetes mellitus. Clinical and Vaccine Immunology 19, 1360-1369.
53. Mathis D & Shoelson SE (2011) Immunometabolism: an emerging frontier. Nature reviews. Immunology 11, 81-83.
54. Mirza S, Hossain M, Mathews C et al. (2012) Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine 57, 136-142.
55. Mito N, Yoshino H, Hosoda T & Sato K (2004) Analysis of the effect of leptin on immune function in vivo using diet-induced obese mice. Journal of Endocrinology 180, 167-173.
56. Mufson MA & Stanek RJ (1999) Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study-1997. American Journal of Medicine 107, 34S-43S.
57. Mugusi F, Swai AB, Alberti KG & McLarty DG (1990) Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle 71, 271-276.
58. Nam JS, Kim AR, Yoon JC et al. (2011) The humoral immune response to the inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with Type 2 diabetes mellitus in Korea. Diabetic Medicine 28, 815-817.
59. Nathan C (2008) Epidemic inflammation: pondering obesity. Molecular Medicine 14, 485-492.
60. Olmos P, Donoso J, Rojas N et al. (1989) [Tuberculosis and diabetes mellitus: a longitudinal-retrospective study in a teaching hospital]. Revista Medica de Chile 117, 979-983.
61. O'rourke RW, Kay T, Scholz MH et al. (2005) Alterations in T-cell subset frequency in peripheral blood in obesity. Obesity Surgery 15, 1463-1468.
62. Pablos-Mendez A, Blustein J & Knirsch CA (1997) The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. American Journal of Public Health 87, 574-579.
63. Peleg AY, Weerarathna T, McCarthy JS & Davis TM (2007) Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes/metabolism research and reviews 23, 3-13.
64. Perez A, Brown HS III & Restrepo BI (2006) Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas. American Journal of Tropical Medicine and Hygiene 74, 604-611.
65. Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27, 813-823.
66. Ponce-De-Leon A, Garcia-Garcia Md ML, Garcia-Sancho MC et al. (2004) Tuberculosis and diabetes in southern Mexico. Diabetes Care 27, 1584-1590.
67. Restrepo BI, Fisher-Hoch SP, Crespo JG et al. (2007) Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiology and Infection 135, 483-491.
68. Restrepo BI, Fisher-Hoch SP, Pino PA et al. (2008) Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clinical Infectious Diseases 47, 634-641.
69. Restrepo BI, Camerlin AJ, Rahbar MH et al. (2011) Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. Bulletin of the World Health Organization 89:352-359. PMCID: PMC3089389.
70. Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJ & Van CR (2010) Implications of the global increase of diabetes for tuberculosis control and patient care. Tropical Medicine and International Health 15, 1289-1299.
71. Santhosh YL, Ramanath KV & Naveen MR (2011) Fungal Infections in diabetes Mellitus: an Overview. International Journal of Pharmaceutical Sciences Review and Research 7, 221-225.
72. Sawant JM (1993) Biochemical changes in polymorphonuclear leucocytes in diabetic patients. Journal of Postgraduate Medicine 39, 183-186.
73. Schaeffler A, Gross P, Buettner R et al. (2009) Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126, 233-245.
74. Sedyaningsih ER, Isfandari S, Setiawaty V et al. (2007) Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006. Journal of Infectious Diseases 196, 522-527.
75. Seshasai SR, Kaptoge S, Thompson A et al. (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. New England Journal of Medicine 364, 829-841.
76. Smith SA & Poland GA (2000) Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 23, 95-108.
77. Smith SA & Poland GA (2003) Immunization and the prevention of influenza and pneumococcal disease in people with diabetes. Diabetes Care 26(Suppl. 1), S126-S128.
78. Smith SA & Poland GA (2004) Influenza and pneumococcal immunization in diabetes. Diabetes Care 27(Suppl. 1), S111-S113.
79. Smith AG, Sheridan PA, Harp JB & Beck MA (2007) Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. Journal of Nutrition 137, 1236-1243.
80. Smith AG, Sheridan PA, Tseng RJ, Sheridan JF & Beck MA (2009) Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology 126, 268-279.
81. Soper GA (1918) THE INFLUENZA PNzrEUMONIA PANDEMIC IN THE AMERICAN ARMY CAMPS DURING SEPTEMBER AND OCTOBER. 1918. Science 48, 451-456.
82. Swai AB, McLarty DG & Mugusi F (1990) Tuberculosis in diabetic patients in Tanzania. Tropical Doctor 20, 147-150.
83. Tang S, Zhang Q, Yu J et al. (2011) Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes. Scandinavian Journal of Infectious Diseases 43, 280-285.
84. Tennenberg SD, Finkenauer R & Dwivedi A (1999) Absence of lipopolysaccharide-induced inhibition of neutrophil apoptosis in patients with diabetes. Archives of Surgery 134, 1229-1233.
85. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schonheyder HC & Sorensen HT (2005) Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clinical Infectious Diseases 40, 628-631.
86. Tilg H & Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 6, 772-783.
87. Tumpey TM, Basler CF, Aguilar PV et al. (2005) Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77-80.
88. Vaillant L, La RG, Tarantola A & Barboza P (2009) Epidemiology of fatal cases associated with pandemic H1N1 influenza. Eurosurveillance Weekly 14, pii: 19309.
89. Van Kerkhove MD, Mumford E, Mounts AW et al. (2011) Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic review. PLoS One 6, e14582.
90. Viswanathan V, Kumpatla S, Aravindalochanan V et al. (2012) Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One 7, e41367.
91. Wang CH, Yu CT, Lin HC, Liu CY & Kuo HP (1999) Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tubercle and Lung Disease 79, 235-242.
92. Webb SA, Pettila V, Seppelt I et al. (2009) Critical care services and 2009 H1N1 influenza in Australia and New Zealand. New England Journal of Medicine 361, 1925-1934.
93. Webster RG & Govorkova EA (2006) H5N1 influenza-continuing evolution and spread. New England Journal of Medicine 355, 2174-2177.
94. Webster RG, Bean WJ, Gorman OT, Chambers TM & Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiological Reviews 56, 152-179.
95. Wolf AM, Wolf D, Rumpold H, Enrich B & Tilg H (2004) Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochemical and Biophysical Research Communications 323, 630-635.
96. World Health Organisation (2011) Global Status Report on non-communicable diseases. Alwan A. 1-176.World Health Organisation, Italy.
97. World Health Organisation (2012) Diabetes Fact Sheet No 312. Geneva. 1-22-2013.
98. World Health Organisation, Diabetes Program (2011) Collaborative Framework for Care and Control of Tuberculosis and Diabetes. World Health Organization, Geneva.
99. Yamashiro S, Kawakami K, Uezu K et al. (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clinical and Experimental Immunology 139, 57-64.
100. Young F, Critchley JA, Johnstone LK & Unwin NC (2009) A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health 5, 9.
101. Zarkesh-Esfahani H, Pockley AG, Wu Z, Hellewell PG, Weetman AP & Ross RJ (2004) Leptin indirectly activates human neutrophils via induction of TNF-alpha. The Journal of Immunology 172, 1809-1814.